Skip to main content

Published locations for WCD: Tofacitinib’s benefits for psoriasis persist for 2 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. WCD: Tofacitinib’s benefits for psoriasis persist for 2 years

User login

  • Reset your password
  • /content/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /edermatologynews/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /familypracticenews/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /internalmedicinenews/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /rheumatologynews/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /rheumatology/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /internalmedicine/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /dermatology/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /familymedicine/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2-years
  • /rheumatology/psoriatic-arthritis-resource-center/article/100370/psoriasis/wcd-tofacitinibs-benefits
  • /dermatology/psoriasiscollection/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist
  • /psoriatic-arthritis-icymi/article/100370/psoriasis/wcd-tofacitinibs-benefits-psoriasis-persist-2